Stromal Vascular Fraction

Global Market Trajectory & Analytics

MCP15044

EXECUTIVE ENGAGEMENTS

POOL

443
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

89
Interactions with Platform & by Email

PARTICIPANTS

18
Unique # Participated

VALIDATIONS

7
Responses Validated*

COMPANIES

25
Responses Validated*
* Login for a full stack data experience

DATE

JUN 2021

TABLES

98

PAGES

214

EDITION

7

PRICE

USD 4950

CODE

MCP15044


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Stromal Vascular Fraction Market to Reach $97.6 Million by 2026

Stromal vascular fraction represents an advanced skin treatment option that is built around stem cell therapy and holds high relevance in the regenerative medicine space. The method involves isolation of cells from adipose tissue of a patient. Obtained through the liposuction process, stromal vascular fraction cells encompass adipose-derived stem cells, endothelial cells, mesenchymal stem cells, leukocytes and tissues containing fat cells. stromal vascular fraction is gaining increasing acceptance across clinical settings for treatment of different chronic conditions. In the recent years, the procedure has witnessed rising significance in diverse areas such as orthopedics, internal medicine, general or plastic surgery and wound healing due to desirable availability, ease of harvest and stable phenotype. Moreover, stromal vascular fraction technique is gaining from several advantages of delivery of these cells through intra-articular injection over surgical implantation, like low cost, less invasiveness and enhanced patient compliance. The global market is slated to receive a significant push from rising number of cosmetic surgeries, increasing incidence of musculoskeletal disorders and growing awareness regarding various merits of stem cell therapy.

Amid the COVID-19 crisis, the global market for Stromal Vascular Fraction estimated at US$75.7 Million in the year 2020, is projected to reach a revised size of US$97.6 Million by 2026, growing at a CAGR of 4.2% over the analysis period. Isolation Products, one of the segments analyzed in the report, is projected to grow at a 4% CAGR to reach US$79.3 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Aspiration Products segment is readjusted to a revised 4.9% CAGR for the next 7-year period. This segment currently accounts for a 16.9% share of the global Stromal Vascular Fraction market. The SVF isolation products segment dominates market share due to rising demand for these products across clinical settings. The rising demand for aesthetic & reconstructive procedures will further boost market prospects.

The U.S. Market is Estimated at $28.2 Million in 2021, While China is Forecast to Reach $7.7 Million by 2026

The Stromal Vascular Fraction market in the U.S. is estimated at US$28.2 Million in the year 2021. The country currently accounts for a 35.89% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$7.7 Million in the year 2026 trailing a CAGR of 5.5% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4% CAGR while Rest of European market (as defined in the study) will reach US$8.1 Million by the end of the analysis period. North America commands a major share of the market, due to increasing demand for reconstructive and aesthetic therapies. The market growth is facilitated by rising awareness pertaining to the use of stem cell therapy to treat several medical conditions and increasing incident of skeletal muscular disorders, including osteoarthritis. The Asia-Pacific region is rapidly emerging as an appealing market on account of continuous expansion of the private healthcare infrastructure and increasing count of private hospitals across rural areas. Stromal vascular fraction is likely to gain from ongoing R&D projects coupled with increasing development and demand for innovative technologies.

Transfer Products Segment to Reach $3.7 Million by 2026

Transfer devices are expected to present new solutions and extend the application scope of stromal vascular fraction. Increasing establishment of private hospitals across urban and rural areas is likely to further bolster the market demand in the coming years. In the global Transfer Products segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.3 Million in the year 2020 will reach a projected size of US$3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$384.2 Thousand by the year 2026.

SELECT PLAYERS

Cellular Biomedicines Group, Inc.; Cytori Therapeutics, Inc.; GE Healthcare; Genesis Biosystems, Inc.; Human Med AG; InGeneron, Inc.; KYOCERA Corporation; Tissue Genesis Inc.

SEGMENTS

» Product Type (Isolation Products, Aspiration Products, Transfer Products) » Application (Soft Tissue, Cosmetic, Orthopedic, Other Applications) » End-Use (Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Other End-Uses)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Stem Cells, Application Areas, and the Different Types: A Prelude
Applications of Stem Cells
Types of Stem Cells
Stromal Vascular Fraction: An Introduction
Production Method for SVF
SVF Cell Procedure
SVF Composition, Content, and Source
SVF: Mechanism of Action
SVF: Clinical Applications
Safety and Efficiency of SVF
Clinical Trials and Regulations Related to SVF
Limitations and Scope
Impact of Covid-19 and a Looming Global Recession
COVID-19 Impact on Stromal Vascular Fraction Market
GLOBAL MARKET OVERVIEW
Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
Soft Tissue Segment Leads the Market
North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
Lucrative Opportunities & Restraints
Market Restraints
Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
Extensive Application Scope
Rising Focus on Non-Enzymatic Isolation Techniques
Strong Research Focus on Optimization of Tissue Recovery
Consistent Efforts to Develop Better Cell Therapies
Competition
Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
Recent Market Activity
SVF Isolation Products Continue to Make Gains
2. FOCUS ON SELECT PLAYERS
PIPELINE ANALYSIS
3. MARKET TRENDS & DRIVERS
Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
EXHIBIT: Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
EXHIBIT: Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019
EXHIBIT 5: Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
Use of SVF in Osteoarthritis Treatment
Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
EXHIBIT: Total Number of Surgical Procedures Performed across the Globe by Plastic Surgeons (2018)
EXHIBIT: Total Number of Surgical Procedures across the Globe by Region of the Body: 2018
Increasing Awareness about Stem Cell Therapy Augurs Well
Innovative Methods Become Relevant in Optimizing Tissue Recovery
Stromal Vascular Formation Holds Significance for Chronic Diseases
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
Stromal Vascular Fraction in Diabetic Care
EXHIBIT 11: Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
The Counterview
Contrast with Regulatory Framework Covering HCT/Ps
Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
EXHIBIT 12: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
High Incidence of Neurological Disorders: A Key Market Driver
EXHIBIT: Annual Incidence of Adult-Onset Neurologic Disorders in the US
EXHIBIT: Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
EXHIBIT: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Expansion of Private Hospitals in Rural Areas
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
World Current & Future Analysis for Isolation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Isolation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Aspiration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Aspiration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Transfer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Transfer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Cosmetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cosmetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Stem Cell Banks/Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Stem Cell Banks/Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
UNITED STATES
USA Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
USA Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
USA Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
CANADA
Canada Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Canada Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Canada Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
JAPAN
Japan Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Japan Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Japan Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
CHINA
China Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
China Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
China Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
EUROPE
Europe Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027
Europe Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Europe Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Europe Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
FRANCE
France Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
France Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
France Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
GERMANY
Germany Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Germany Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Germany Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
ITALY
Italy Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Italy Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Italy Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
UK Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
UK Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Rest of Europe Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Rest of Europe Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Asia-Pacific Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Asia-Pacific Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2021 & 2027
Rest of World Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2021 & 2027
Rest of World Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2021 & 2027
Total Companies Profiled: 25

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com